메뉴 건너뛰기
Nuclear Medicine Communications
Volumn 22, Issue 2, 2001, Pages 257-260
Does simple estimation of 131i-meta-iodobenzylguanidine uptake in patients with neural crest tumours correlate with clinical outcome?
Author keywords

Dosimetry; Iodine 131 MIBG; Neural crest tumours; Therapy
Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;
EID: 0034745470     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200102000-00019     Document Type: Review
Times cited : (2)
References (11)
  • 1
    • 0030730460 scopus 로고    scopus 로고
    • Towards the goal of cancer-specific imaging and therapy.
    • Britton KE. Towards the goal of cancer-specific imaging and therapy. Nuc Med Commun 1997; 18: 992-1007.
    • (1997) Nuc Med Commun , vol.18 , pp. 992-1007
    • Britton, K.E.1
  • 2
    • 0028245761 scopus 로고
    • Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.
    • Wafelman AR, Hoefnagel CA, Maes RAA et al. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry. Eur J Nucl Med 1994; 21: 545-559.
    • (1994) Eur J Nucl Med , vol.21 , pp. 545-559
    • Wafelman, A.R.1    Hoefnagel, C.A.2    Maes, R.3
  • 3
    • 0020959819 scopus 로고
    • The normal and abnormal distribution of the adrenomedullary imaging agent m-I-131 iodobenzylguanidine (I-131) in man: Evaluation by scintigraphy.
    • Nakajo M, Shapiro J, Copp V et al. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131] iodobenzylguanidine (I-131) in man: Evaluation by scintigraphy. J Nucl Med 1983; 24: 672-682.
    • (1983) J Nucl Med , vol.24 , pp. 672-682
    • Nakajo, M.1    Shapiro, J.2    Copp, V.3
  • 4
    • 0023715701 scopus 로고
    • Toxicity from treatment of neuroblastoma with 131I metaiodobenzylguanidine.
    • Sisson JC, Hutchinson RJ, Carey JE et al. Toxicity from treatment of neuroblastoma with 131I metaiodobenzylguanidine. Eur J Nucl Med 1980; 14: 337-340.
    • (1980) Eur J Nucl Med , vol.14 , pp. 337-340
    • Sisson, J.C.1    Hutchinson, R.J.2    Carey, J.E.3
  • 5
    • 0026357917 scopus 로고
    • 131I-Metaiodobenzylguanidine treatment of malignant phaeochromocytoma: Experience of the Rome group.
    • 131I-Metaiodobenzylguanidine treatment of malignant phaeochromocytoma: Experience of the Rome group. J Nucl Biol Med 1991; 35: 295-299.
    • (1991) J Nucl Biol Med , vol.35 , pp. 295-299
    • Troncone, L.1    Rufini, V.2    Daidone, M.S.3
  • 6
    • 0029039992 scopus 로고
    • First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
    • De Kraker J, Hoefnagel CA, Caron H et al. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma. Eur J Cancer 1995; 31A: 600-602.
    • (1995) Eur J Cancer , vol.31A , pp. 600-602
    • De Kraker, J.1    Hoefnagel, C.A.2    Caron, H.3
  • 7
    • 0027093713 scopus 로고
    • Phase III study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Childrens Cancer Study Group investigation.
    • Lashford LS, Lewis IJ, Fielding SL et al. Phase I/II study of iodine 131 metaiodobenzylguanidine in chemoresistant neuroblastoma: a United Kingdom Children’s Cancer Study Group investigation. J Clin Oncol 1992; 10: 1889-1896.
    • (1992) J Clin Oncol , vol.10 , pp. 1889-1896
    • Lashford, L.S.1    Lewis, I.J.2    Fielding, S.L.3
  • 8
    • 0029066978 scopus 로고
    • A new approach in the treatment of stage IV neuroblastoma using a combination of 131I meta-iodobenylguanidine (MIBG) and cisplatin.
    • 131I] meta-iodobenylguanidine (MIBG) and cisplatin. Eur J Cancer 1995; 31A: 606-611.
    • (1995) Eur J Cancer , vol.31A , pp. 606-611
    • Mastrangelo, R.1    Tornesello, A.2    Riccardi, R.3
  • 9
    • 0025868778 scopus 로고
    • Metaiodobenzylguanidine in the treatment of 47 patients with neuroblastoma: results of the German neuroblastoma trial.
    • Klingbiel T, Berhold F, Treuner J et al. Metaiodobenzylguanidine in the treatment of 47 patients with neuroblastoma: results of the German neuroblastoma trial. Med Pediatr Onc 1991; 19: 84-88.
    • (1991) Med Pediatr Onc , vol.19 , pp. 84-88
    • Klingbiel, T.1    Berhold, F.2    Treuner, J.3
  • 10
    • 0000757480 scopus 로고    scopus 로고
    • Patient specific dosimetry for radionuclide therapy. (Abstract presented at the 26th Annual Meeting of the British Nuclear Medicine Society.
    • Flux GD, Guy SJ, Chittenden MA et al. Patient specific dosimetry for radionuclide therapy. (Abstract presented at the 26th Annual Meeting of the British Nuclear Medicine Society.) Nucl Med Commun 1998; 19: 377.
    • (1998) ) Nucl Med Commun , vol.19 , pp. 377
    • Flux, G.D.1    Guy, S.J.2    Chittenden, M.A.3
  • 11
    • 0000757480 scopus 로고    scopus 로고
    • Improved accuracy of whole body prediction for 131I-MIBG therapy. (Abstract presented at the 26th Annual Meeting of the British Nuclear Medicine Society.
    • 131I-MIBG therapy. (Abstract presented at the 26th Annual Meeting of the British Nuclear Medicine Society.) Nucl Med Commun 1998; 19: 377.
    • (1998) ) Nucl Med Commun , vol.19 , pp. 377
    • Chittenden, S.J.1    Flux, K.2    Cody, K.J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.